|
|
Article: Correction to Press Release: New Data Show Early Use of Anti-Platelet Therapy Reduced Combined Death or Subsequent Heart Attacks in High-Risk Heart Attack Patients; -- Results from CRUSADE support treatment guidelines --.
- Article from:
- PR Newswire
- Article date:
- September 19, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Millennium Pharmaceuticals, Inc. and Schering-Plough Corporation today issued a correction to a press release issued September 17, 2003 that reported on clinical data presented at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. The revised press release clarifies statements regarding the statistical significance of the findings and corrects certain data as follows.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
In the prior release, it was reported that "after adjusting for various risk factors, using a GP IIb-IIIa inhibitor 'upstream,' or before a patient is taken to the catheterization lab, ...